LatestCorporate Compliance 5 October 2026
Compliance Calendar Updates Boost Investor Confidence
Sai Life Sciences filed its Q2 FY27 Demat Certificate, confirming adherence to SEBI Depositories and Participants Regulations for 2026, while Vice President CP Radhakrishnan highlighted the importance of corporate transparency and investor confidence during the ICSI Foundation Day, emphasizing the upcoming compliance calendar for 2027. These moves aim to strengthen market trust and ensure regulatory alignment across major Indian corporations.
Sai Life Sciences has submitted its Q2 FY27 Demat Certificate, meeting SEBI’s 2018 Depositories and Participants Regulations and confirming compliance for 2026.
- Key point: The filing aligns with the company’s compliance calendar and reinforces regulatory transparency. Read more
Vice President CP Radhakrishnan, speaking at the ICSI Foundation Day, stressed the need for corporate transparency and investor confidence, citing the upcoming 2027 compliance calendar as a critical driver for market stability.
- Key point: His remarks underscore the government’s focus on clear disclosure standards. Read more
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.